1-8 of 8
Arun Sreekumar
Close
Sort by
Journal Articles

Dnmt3a loss and Idh2 neomorphic mutations mutually potentiate malignant hematopoiesis

Xiaotian Zhang, Xinyu Wang, Xue Qing David Wang, Jianzhong Su, Nagireddy Putluri, Ting Zhou, Ying Qu, Mira Jeong, Anna Guzman, Carina Rosas, Yun Huang, Arun Sreekumar, Wei Li, Margaret A. Goodell
Journal: Blood
Blood (2020) 135 (11): 845–856.
https://doi.org/10.1182/blood.2019003330
Published: 2020
Includes: Supplemental data
Journal Articles

Combined Effect Of Dnmt3a Loss-Of-Function and Idh2 neomorphic mutation Promotes Hematopoietic Malignancy

Xiaotian Zhang, B.S, Ting Zhou, M.D., Putluri Nagireddy, PhD, George Michailidis, PhD, Mira Jeong, Ph.D., Arun Sreekumar, PhD, Vivienne I. Rebel, MD, PhD, Margaret A. Goodell, PhD
Journal: Blood
Blood (2013) 122 (21): 884.
https://doi.org/10.1182/blood.V122.21.884.884
Published: 2013
Journal Articles

Proteomic Signature Predicting Achievement of Very Good Partial Response In Patients with Multiple Myeloma Based On Complementary Label-Free and iTRAQ Quantitative Proteome Analysis

Dominik Dytfeld, MD, PhD, Malathi Kandarpa, PhD, John R Strahler, PhD, Dattatreya Mellacheruvu, Suchitra Subramani, Stephanie J Kraftson, Lambert Ngoka, PhD, Alexey Nesvizhskii, PhD, Arun Sreekumar, PhD, Andrzej J Jakubowiak, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1902.
https://doi.org/10.1182/blood.V116.21.1902.1902
Published: 2010
Journal Articles

Proteomic Profiling of Multiple Myeloma (MM) Cells Using iTRAQ and Label-Free Quantitative Proteomics for the Prediction of Complete or near Complete Response (CR/nCR) In Frontline Treatment with Lenalidomide, Bortezomib, and Dexamethasone

Dominik Dytfeld, MD, PhD, Malathi Kandarpa, PhD, John R Strahler, PhD, Dattatreya Mellacheruvu, Suchitra Subramani, Stephanie J Kraftson, Lambert Ngoka, PhD, Alexey Nesvizhskii, PhD, Arun Sreekumar, PhD, Paul G Richardson, MD, Andrzej J Jakubowiak, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 618.
https://doi.org/10.1182/blood.V116.21.618.618
Published: 2010
Journal Articles

Proteomic Profiling of Multiple Myeloma Using iTRAQ Labeling Followed by Multidimensional Liquid Chromatography and Tandem Mass Spectrometry.

Dominik Dytfeld, MD, PhD, Malathi Hari, PhD, John Strahler, PhD, Dattatreya Mellacheruvu, Suchitra Subramani, Alexey Nesvizhskii, PhD, Arun Sreekumar, PhD, Andrzej J Jakubowiak, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4865.
https://doi.org/10.1182/blood.V114.22.4865.4865
Published: 2009
Journal Articles

Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells

Warren Fiskus, Yongchao Wang, Arun Sreekumar, Kathleen M. Buckley, Huidong Shi, Anand Jillella, Celalettin Ustun, Rekha Rao, Pravina Fernandez, Jianguang Chen, Ramesh Balusu, Sanjay Koul, Peter Atadja, Victor E. Marquez, Kapil N. Bhalla
Journal: Blood
Blood (2009) 114 (13): 2733–2743.
https://doi.org/10.1182/blood-2009-03-213496
Published: 2009
Includes: Supplemental data
Journal Articles

A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification

Dorothee Mueller, Christian Bach, Deniz Zeisig, Maria-Paz Garcia-Cuellar, Sara Monroe, Arun Sreekumar, Rong Zhou, Alexey Nesvizhskii, Arul Chinnaiyan, Jay L. Hess, Robert K. Slany
Journal: Blood
Blood (2007) 110 (13): 4445–4454.
https://doi.org/10.1182/blood-2007-05-090514
Published: 2007
Journal Articles

Purification of an MLL Partner Associated Complex (MPAC) Suggests a Common Role for MLL Fusion Partners in Transcriptional Elongation.

Robert K. Slany, PhD, Dorothee Mueller, Christian Bach, Deniz Zeisig, Maria-Paz Garcia-Cuellar, Ph.D., Sara Monroe, Ph.D., Arun Sreekumar, Ph.D., Ron Zhao, Ph.D., Alexey Nesvizhskii, Ph.D., Arul Chinnaiyan, Ph.D., Jay L. Hess, M.D. Ph.D.
Journal: Blood
Blood (2006) 108 (11): 770.
https://doi.org/10.1182/blood.V108.11.770.770
Published: 2006